Validation of a New DNA Extraction Method from Agar or Liquid Swabs for Molecular Detection of MRSA, VRE and KPC Utilizing the NanoCHIP® Microarray Technology

22 May 2014

Hospital acquired infections can be widely prevented through screening of patients before or during hospital admission, and proper patient isolation and management. This study, presented at ECCMID 2014, demonstrates the compatibility of different swabs, with new PCR - NanoCHIP® technology for screening large number of samples for simultaneous detection of MRSA, VRE and KPC in variety of clinical samples.

NanoCHIP® XL Analyzer

Savyon Diagnostics

The NanoChip® system is an automated, multi-purpose instrument which is used for clinical molecular diagnostics. Clinical microbiology, genetics/cytogenetics and pathology laboratories use this convenient platform to identify pathogenic infections, carriage of genetic disorders, predisposition to diseases and response to pharmaceutical therapies. The NanoCHIP® technology is intended for those users that require: Medium-to high throughput Multiplex molecular testing (over 4 markers/sample) Automation Simplicity Full LIS connectivity

(0)

Links

Tags

Validation of a New DNA Extraction Method from Agar or Liquid Swabs for Molecular Detection of MRSA, VRE and KPC Utilizing the NanoCHIP® Microarray Technology